3 ms·
In evolution adaptation prevails over customary behaviors thought of as morals. The question is why have the generic makers continued to cooperate instead of de
by adolph 6y ago
In evolution adaptation prevails over customary behaviors thought of as morals. The question is why have the generic makers continued to cooperate instead of defect? How is the cartel protected?
In this thought I am reminded of the Econtalk podcast’s discussion of Martin Shkreli in the interview about the High Cost of Cancer Drugs with Vincent Rajkumar.
http://www.econtalk.org/vincent-rajkumar-on-the-high-price-of-cancer-drugs/ http://www.econtalk.org/vincent-rajkumar-on-the-high-price-o...
http://www.econtalk.org/extra/the-high-cost-of-cancer/ http://www.econtalk.org/extra/the-high-cost-of-cancer/
- ficklepickle 6y agoOne tactic pharma companies use is playing games so generic makers can't get samples of the medication. These samples are required for making a generic version. I read this somewhere but don't have a link.
- adolph 6y agoThat seems like evolutionarily adaptive and expectable behavior for a corporate collective in that context, yes.